person · Reporting owner
Engelbert Catherine M.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MCDONALDS CORPMCD · Entity 2849 | Director | December 31, 2025 | January 05, 2026 |
| Royalty Pharma plcRPRX · Entity 3100 | Director | June 05, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MCDONALDS CORP
Report date December 31, 2025 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 4,673.99 |
Reported balance
After 2025-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-31 · Grant · Acquired 670.75 · Balance 4,673.99 F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan"). F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4: Includes shares acquired through dividend reinvestment. |
| Common StockSEC Table I · non-derivative | Direct | 2,079 |
Reported balance
Holding disclosure · report date 2025-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,079 |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan").
F2: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation.
F3: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board.
F4: Includes shares acquired through dividend reinvestment.
Royalty Pharma plc
Report date June 05, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary SharesSEC Table I · non-derivative | Direct | 55,673 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 4,545 · Balance 55,673 F1: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2026 Filed Jun 8, 2026 20:22 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 4,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001796439-26-000003 · wk-form4_1780950154.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,673 F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 16:52 UTC | MCDONALDS CORP MCD · Entity 2849 | GrantPhantom Stock · Derivative | 670.75 | $305.63 | $205,001.32 |
DisclosureSEC source: 0000063908-26-000019 · form4.xml · derivative · entry 2 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,673.99 Underlying: Common Stock · 670.75 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Board of Directors' Deferred Compensation Plan (the "Plan"). F2 · kind: Acquisition of phantom stock pursuant to the Plan in a transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3 · derivative.exercise_date: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F3 · derivative.expiration_date: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:41 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 7,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001802768-25-000061 · wk-form4_1747345286.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,128 F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:31 UTC | MCDONALDS CORP MCD · Entity 2849 | GrantPhantom Stock · Derivative | 700.47 | $289.89 | $203,059.25 |
DisclosureSEC source: 0001567619-25-000010 · form4.xml · derivative · entry 2 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,910.99 Underlying: Common Stock · 700.47 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the "Plan"). F2 · kind: Acquisition of phantom stock pursuant to the Plan in transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3 · derivative.exercise_date: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F3 · derivative.expiration_date: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document |
| June 07, 2024 Filed Jun 10, 2024 20:12 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 9,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001802768-24-000029 · wk-form4_1718050336.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,514 F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 21:12 UTC | MCDONALDS CORP MCD · Entity 2849 | GrantPhantom Stock · Derivative | 674.51 | $296.51 | $199,998.96 |
DisclosureSEC source: 0000063908-24-000012 · form4.xml · derivative · entry 2 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,133.65 Underlying: Common Stock · 674.51 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the "Plan"). F2 · kind: Acquisition of phantom stock pursuant to the Plan in transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3 · derivative.exercise_date: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F3 · derivative.expiration_date: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 20:05 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 7,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-039681 · doc4.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,211 F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. Read SEC document |
| April 03, 2023 Filed Aug 4, 2023 21:55 UTC | MCDONALDS CORP MCD · Entity 2849 | PurchaseCommon Stock | 38 | $281.03 | $10,679.14 |
DisclosureSEC source: 0000063908-23-000078 · form4.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,079 Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 19:46 UTC | MCDONALDS CORP MCD · Entity 2849 | GrantPhantom Stock · Derivative | 726.49 | $263.53 | $191,451.91 |
DisclosureSEC source: 0001567619-23-000147 · doc1.xml · derivative · entry 2 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,405.34 Underlying: Common Stock · 726.49 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the "Plan"). F2 · kind: Acquisition of phantom stock pursuant to the Plan in transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3 · derivative.exercise_date: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F3 · derivative.expiration_date: Payment of phantom stock will occur following the Director's retirement date or other termination from the Board. F4 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document |
| June 24, 2022 Filed Jun 24, 2022 20:59 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 6,328 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-024044 · doc4.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,464 F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 19:34 UTC | MCDONALDS CORP MCD · Entity 2849 | PurchaseCommon Stock | 1,000 | $244.18 | $244,180.00 |
DisclosureSEC source: 0001567619-22-006022 · doc1.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,041 F1 · balance_after: Includes previously unreported shares that were acquired through dividend reinvestment. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 17:09 UTC | MCDONALDS CORP MCD · Entity 2849 | GrantPhantom Stock · Derivative | 690.12 | $268.07 | $185,000.47 |
DisclosureSEC source: 0001567619-22-000153 · doc1.xml · derivative · entry 2 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641.27 Underlying: Common Stock · 690.12 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the "Plan"). F2 · kind: Acquisition of phantom stock pursuant to the Plan in transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3 · derivative.exercise_date: Payment of phantom stock will be deferred until at least April of the year following the Director's retirement date or other termination from the Board. F3 · derivative.expiration_date: Payment of phantom stock will be deferred until at least April of the year following the Director's retirement date or other termination from the Board. F4 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document |
| June 25, 2021 Filed Jun 30, 2021 00:22 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 5,726 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-009687 · dp153558_4-engelbert.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,136 F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 17:08 UTC | MCDONALDS CORP MCD · Entity 2849 | GrantPhantom Stock · Derivative | 862.15 | $214.58 | $185,000.15 |
DisclosureSEC source: 0001567619-21-000161 · doc1.xml · derivative · entry 2 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 930.63 Underlying: Common Stock · 862.15 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the "Plan"). F2 · kind: Acquisition of phantom stock pursuant to the Plan in transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3 · derivative.exercise_date: Payment of phantom stock may be deferred until the earlier of (a) April of the year following the Director's retirement date or other termination from the Board; or (b) a specific future date pursuant to an election. F3 · derivative.expiration_date: Payment of phantom stock may be deferred until the earlier of (a) April of the year following the Director's retirement date or other termination from the Board; or (b) a specific future date pursuant to an election. F4 · balance_after: Includes shares acquired through dividend reinvestment. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 23:08 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 910 | $41.17 | $37,468.43 |
DisclosureSEC source: 0000950103-20-019589 · dp138285_4-engelbert.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,410 Read SEC document |
| June 18, 2020 Filed Sep 24, 2020 00:29 UTC | Royalty Pharma plc RPRX · Entity 3100 | GrantClass A Ordinary Shares | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-20-018599 · dp137243_4-engelbert.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 20:07 UTC | MCDONALDS CORP MCD · Entity 2849 | PurchaseCommon Stock | 1,000 | $192.13 | $192,130.00 |
DisclosureSEC source: 0001567619-20-005417 · doc1.xml · nonDerivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 18:17 UTC | MCDONALDS CORP MCD · Entity 2849 | GrantPhantom Stock · Derivative | 66.69 | $197.61 | $13,178.61 |
DisclosureSEC source: 0001567619-20-000206 · doc1.xml · derivative · entry 1 Engelbert Catherine M. · CIK 0001796439 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66.69 Underlying: Common Stock · 66.69 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of McDonald's Corporation common stock and shall be settled in cash, pursuant to the Directors' Deferred Compensation Plan (the "Plan"). F2 · kind: Acquisition of phantom stock pursuant to the Plan in transaction exempt under Rule 16b-3(d)(1). Amount represents deferred compensation. F3 · derivative.exercise_date: Payment of phantom stock may be deferred until the earlier of (a) April of the year following the Director's retirement date or other termination from the Board; or (b) a specific future date pursuant to an election. F3 · derivative.expiration_date: Payment of phantom stock may be deferred until the earlier of (a) April of the year following the Director's retirement date or other termination from the Board; or (b) a specific future date pursuant to an election. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.